Literature DB >> 31167058

Lack of Glycemic Legacy Effects in the Veterans Affairs Diabetes Trial.

Kasia J Lipska1, Neda Laiteerapong1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31167058      PMCID： PMC7307414          DOI： 10.1056/NEJMe1905495

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.

Authors: 
Journal:  Diabetes Care       Date:  2016-02-09       Impact factor: 19.112

2.  Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.

Authors:  Silvio E Inzucchi; Mikhail Kosiborod; David Fitchett; Christoph Wanner; Uwe Hehnke; Stefan Kaspers; Jyothis T George; Bernard Zinman
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

3.  Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.

Authors:  Rodney A Hayward; Peter D Reaven; Wyndy L Wiitala; Gideon D Bahn; Domenic J Reda; Ling Ge; Madeline McCarren; William C Duckworth; Nicholas V Emanuele
Journal:  N Engl J Med       Date:  2015-06-04       Impact factor: 91.245

4.  Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up.

Authors:  Peter D Reaven; Nicholas V Emanuele; Wyndy L Wiitala; Gideon D Bahn; Domenic J Reda; Madeline McCarren; William C Duckworth; Rodney A Hayward
Journal:  N Engl J Med       Date:  2019-06-06       Impact factor: 91.245

5.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

6.  Glucose control and vascular complications in veterans with type 2 diabetes.

Authors:  William Duckworth; Carlos Abraira; Thomas Moritz; Domenic Reda; Nicholas Emanuele; Peter D Reaven; Franklin J Zieve; Jennifer Marks; Stephen N Davis; Rodney Hayward; Stuart R Warren; Steven Goldman; Madeline McCarren; Mary Ellen Vitek; William G Henderson; Grant D Huang
Journal:  N Engl J Med       Date:  2008-12-17       Impact factor: 91.245

7.  Metabolic memory and all-cause death in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.

Authors:  T M E Davis; S A P Chubb; D G Bruce; W A Davis
Journal:  Diabetes Obes Metab       Date:  2016-04-12       Impact factor: 6.577

8.  Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes.

Authors: 
Journal:  Diabetes Care       Date:  2016-01-28       Impact factor: 19.112

9.  Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Authors:  Sophia Zoungas; John Chalmers; Bruce Neal; Laurent Billot; Qiang Li; Yoichiro Hirakawa; Hisatomi Arima; Helen Monaghan; Rohina Joshi; Stephen Colagiuri; Mark E Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Liu Lisheng; Giuseppe Mancia; Michel Marre; David R Matthews; Carl E Mogensen; Vlado Perkovic; Neil Poulter; Anthony Rodgers; Bryan Williams; Stephen MacMahon; Anushka Patel; Mark Woodward
Journal:  N Engl J Med       Date:  2014-09-19       Impact factor: 91.245

10.  The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).

Authors:  Neda Laiteerapong; Sandra A Ham; Yue Gao; Howard H Moffet; Jennifer Y Liu; Elbert S Huang; Andrew J Karter
Journal:  Diabetes Care       Date:  2018-08-13       Impact factor: 17.152
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.